Clinical Trials
5
Active:1
Completed:1
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Combined Prospective and Retrospective Post-Market Follow Up of the 'BPK-S Integration' UC as Primary Implant in the Variant CoCr
Completed
- Conditions
- Osteoarthritis, KneeJoint Instability
- First Posted Date
- 2018-01-23
- Last Posted Date
- 2020-03-06
- Lead Sponsor
- Peter Brehm GmbH
- Target Recruit Count
- 62
- Registration Number
- NCT03406637
- Locations
- 🇧🇪
Centre Hospitalier de Wallonie picarde - CHwapi A.S.B.L, Tournai, Belgium
🇧🇪Medical Center Tournai, Tournai, Belgium
Post-market Follow up Study of the 'BPK-S Integration' UC as Primary Implant in the Variants CoCr or Ceramic
Terminated
- Conditions
- ArthritisJoint DiseaseMusculoskeletal DiseaseJoint InstabilityRheumatic DiseasesOsteoarthritisOsteoarthritis, Knee
- First Posted Date
- 2017-09-26
- Last Posted Date
- 2019-11-19
- Lead Sponsor
- Peter Brehm GmbH
- Target Recruit Count
- 28
- Registration Number
- NCT03293719
- Locations
- 🇦🇹
SMZ Ost, Donauspital, Vienna, Oberösterreich, Austria
Prospective Post Market Clinical Follow-Up of the Primary Knee Endoprosthesis BPK-S Integration
Terminated
- Conditions
- Osteoarthritis, KneeJoint Instability
- First Posted Date
- 2015-11-26
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- Peter Brehm GmbH
- Target Recruit Count
- 124
- Registration Number
- NCT02615522
- Locations
- 🇦🇹
Landesklinikum Amstetten, Amstetten, Niederoesterreich, Austria
News
No news found